| PERIOD ENDING | 29-Mar-09 | 31-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 10,373,000 | 11,132,000 | 10,577,000 | 11,039,000 | | Cost of Revenue | 9,368,000 | 9,865,000 | 9,455,000 | 9,848,000 | | | Gross Profit | 1,005,000 | 1,267,000 | 1,122,000 | 1,191,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
|
-
|
-
|
-
| | Non Recurring |
-
| (108,000) |
-
|
-
| | Others | (52,000) | 316,000 | (120,000) | (172,000) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,057,000 | 1,059,000 | 1,242,000 | 1,363,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,000) | (102,000) | (13,000) | 34,000 | | Earnings Before Interest And Taxes | 1,054,000 | 1,246,000 | 1,229,000 | 1,397,000 | | Interest Expense | 76,000 | 77,000 | 85,000 | 92,000 | | Income Before Tax | 978,000 | 1,169,000 | 1,144,000 | 1,305,000 | | Income Tax Expense | 312,000 | 346,000 | 362,000 | 423,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 666,000 | 823,000 | 782,000 | 882,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 666,000 | 823,000 | 782,000 | 882,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $666,000 | $823,000 | $782,000 | $882,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
